Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


04.09.2017

1 Acta Haematol
18 Blood
1 Br J Cancer
3 Cancer
1 Int J Hematol
1 J Clin Oncol
1 J Pediatr Hematol Oncol
3 Leuk Lymphoma
1 Leuk Res
2 Leukemia
1 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Haematol

  1. LIEBERMAN F, Villgran V, Normolle D, Boyiadzis M, et al
    Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis.
    Acta Haematol. 2017;138:116-118.
    PubMed     Text format    


    Blood

  2. COMOLI P, Basso S, Riva G, Barozzi P, et al
    BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
    Blood. 2017;129:582-586.
    PubMed     Text format     Abstract available

  3. DOHNER H, Estey E, Grimwade D, Amadori S, et al
    Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
    Blood. 2017;129:424-447.
    PubMed     Text format     Abstract available

  4. KNAPPER S, Russell N, Gilkes A, Hills RK, et al
    A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML.
    Blood. 2017;129:1143-1154.
    PubMed     Text format     Abstract available

  5. PRATZ KW, Levis M
    How I treat FLT3-mutated AML.
    Blood. 2017;129:565-571.
    PubMed     Text format     Abstract available

  6. WILLIAMS KM
    How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Blood. 2016 Nov 16. pii: blood-2016-08-693507.
    PubMed     Text format     Abstract available

  7. CHESNAIS V, Arcangeli ML, Delette C, Rousseau A, et al
    Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
    Blood. 2017;129:484-496.
    PubMed     Text format     Abstract available

  8. CUSAN M, Vegi NM, Mulaw MA, Bamezai S, et al
    Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N-terminus.
    Blood. 2016 Nov 8. pii: blood-2016-04-706978.
    PubMed     Text format     Abstract available

  9. ALSULIMAN A, Muftuoglu M, Khoder A, Ahn YO, et al
    A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.
    Blood. 2017;129:740-758.
    PubMed     Text format     Abstract available

  10. MYKLEBUST JH, Brody J, Kohrt HE, Kolstad A, et al
    Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Blood. 2017;129:759-770.
    PubMed     Text format     Abstract available

  11. AGARWAL P, Zhang B, Ho Y, Cook A, et al
    Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI.
    Blood. 2017;129:1008-1020.
    PubMed     Text format     Abstract available

  12. LEHNERTZ B, Zhang YW, Boivin I, Mayotte N, et al
    H3K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations.
    Blood. 2017 Aug 30. pii: blood-2017-03-774653. doi: 10.1182/blood-2017-03-774653
    PubMed     Text format     Abstract available

  13. ANDERSON MA, Tam C, Lew TE, Juneja S, et al
    Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax.
    Blood. 2017;129:3362-3370.
    PubMed     Text format     Abstract available

  14. MALCOVATI L, Galli A, Travaglino E, Ambaglio I, et al
    Clinical significance of somatic mutation in unexplained blood cytopenia.
    Blood. 2017;129:3371-3378.
    PubMed     Text format     Abstract available

  15. RESHMI SC, Harvey RC, Roberts KG, Stonerock E, et al
    Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.
    Blood. 2017;129:3352-3361.
    PubMed     Text format     Abstract available

  16. DOURADO KMC, Baik J, Oliveira VKP, Beltrame M, et al
    Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models.
    Blood. 2017;129:2526-2536.
    PubMed     Text format     Abstract available

  17. HUGHES A, Clarson J, Tang C, Vidovic L, et al
    CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors.
    Blood. 2017;129:1166-1176.
    PubMed     Text format     Abstract available

  18. SHAFAT MS, Oellerich T, Mohr S, Robinson SD, et al
    Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.
    Blood. 2017;129:1320-1332.
    PubMed     Text format     Abstract available

  19. REITER A, Gotlib J
    Myeloid neoplasms with eosinophilia.
    Blood. 2017;129:704-714.
    PubMed     Text format     Abstract available


    Br J Cancer

  20. CHERNYAVSKIY P, Edmondson EF, Weil MM, Little MP, et al
    High-energy particle beam and gamma radiation exposure, familial relatedness and cancer in mice.
    Br J Cancer. 2017;117:41-50.
    PubMed     Text format     Abstract available


    Cancer

  21. MARINA NM, Liu Q, Donaldson SS, Sklar CA, et al
    Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Cancer. 2017;123:2551-2560.
    PubMed     Text format     Abstract available

  22. ALVAREZ E, Keegan T, Johnston EE, Haile R, et al
    Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
    Cancer. 2017;123:2516-2523.
    PubMed     Text format     Abstract available

  23. YUCEL OK, Saliba RM, Rondon G, Ahmed S, et al
    Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogenic stem cell transplantation using reduced intensity conditioning.
    Cancer. 2017 Mar 21. doi: 10.1002/cncr.30632.
    PubMed     Text format     Abstract available


    Int J Hematol

  24. ASOU N, Fujita H, Shinagawa K
    JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia: 2. Acute promyelocytic leukemia (APL).
    Int J Hematol. 2017 Aug 30. doi: 10.1007/s12185-017-2318.
    PubMed     Text format    


    J Clin Oncol

  25. TEEPEN JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, et al
    Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    J Clin Oncol. 2017;35:2288-2298.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  26. MARTINEZ-ROMERA I, Villa M, Areal P, Rodrigo E, et al
    Hemophagocytic Lymphohistiocytosis: A Dangerous Intruder in Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Aug 30. doi: 10.1097/MPH.0000000000000932.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  27. CAO H, Xie J, Guo L, Han K, et al
    All-trans retinoic acid induces autophagic degradation of ubiquitin-like modifier activating enzyme 3 in acute promyelocytic leukemia cells.
    Leuk Lymphoma. 2017 Aug 29:1-9. doi: 10.1080/10428194.2017.1365850.
    PubMed     Text format     Abstract available

  28. BURGSTALLER S, Stauder R, Kuehr T, Lang A, et al
    A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
    Leuk Lymphoma. 2017 Aug 30:1-6. doi: 10.1080/10428194.2017.1369070.
    PubMed     Text format     Abstract available

  29. HUANG A, Huang C, Tang G, Cheng H, et al
    Impact of clinical utility of MRD assessment with different techniques on survival in acute B lymphoblastic leukemia.
    Leuk Lymphoma. 2017 Aug 31:1-11. doi: 10.1080/10428194.2017.1369072.
    PubMed     Text format     Abstract available


    Leuk Res

  30. FRAIRIA C, Aydin S, Audisio E, Riera L, et al
    Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: A retrospective cohort study.
    Leuk Res. 2017;61:10-17.
    PubMed     Text format     Abstract available


    Leukemia

  31. DEGRYSE S, de Bock CE, Demeyer S, Govaerts I, et al
    Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.
    Leukemia. 2017 Aug 30. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  32. KOEFFLER HP, Leong G
    Preleukemia: one name, many meanings.
    Leukemia. 2017;31:534-542.
    PubMed     Text format     Abstract available


    N Engl J Med

  33. BRAUN R, Holler E
    Acute Ocular Graft-versus-Host Disease.
    N Engl J Med. 2017;377:676.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: